Oncology Institute (NASDAQ:TOI) Announces Earnings Results, Misses Estimates By $0.06 EPS

Oncology Institute (NASDAQ:TOI) issued its earnings results on Monday. The company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.06), Zacks reports. The business had revenue of $100.27 million for the quarter, compared to the consensus estimate of $109.15 million. Oncology Institute had a negative net margin of 17.63% and a negative return on equity of 186.83%. Oncology Institute updated its FY 2025 guidance to EPS.

Oncology Institute Stock Performance

NASDAQ:TOI opened at $1.26 on Wednesday. The business’s fifty day moving average is $0.82 and its 200 day moving average is $0.46. The firm has a market cap of $95.20 million, a price-to-earnings ratio of -1.62 and a beta of 0.41. Oncology Institute has a 52-week low of $0.13 and a 52-week high of $1.89. The company has a debt-to-equity ratio of 5.91, a quick ratio of 2.27 and a current ratio of 2.49.

About Oncology Institute

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.